Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avidity Biosciences Inc
(NQ:
RNA
)
47.30
+0.25 (+0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avidity Biosciences Inc
< Previous
1
2
3
4
5
6
Next >
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
September 13, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food...
Via
FinancialNewsMedia
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
What 10 Analyst Ratings Have To Say About Avidity Biosciences
May 17, 2023
Via
Benzinga
Avidity Biosciences Touts Encouraging Data From Myotonic Dystrophy Type 1 Study
April 28, 2023
Avidity Biosciences Inc (NASDAQ: RNA) announced
Via
Benzinga
After Falling 18% in 1 Day, Is This Growth Stock Done For?
April 11, 2023
It's too soon to predict doom, but that doesn't mean things are good.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
May 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Avidity Biosciences
March 31, 2023
Via
Benzinga
Expert Ratings for Avidity Biosciences
March 31, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Where Avidity Biosciences Stands With Analysts
August 09, 2023
Via
Benzinga
Why Avidity Biosciences Shares Are Sliding Today
March 30, 2023
Via
Benzinga
Expert Ratings for Avidity Biosciences
March 01, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
During the Friday's sesion, 157 stocks hit new 52-week lows.
Via
Benzinga
FDA Eases Partial Hold On Avidity Biosciences' Investigational Drug Study In Type Of Dystrophy
May 17, 2023
The FDA has eased the partial clinical hold on Avidity Biosciences Inc's (NASDAQ: RNA) AOC 1001, allowing Avidity to double the number of participants in the MARINA Open-Label Extension (MARINA-OLE)...
Via
Benzinga
US Stocks Mixed; Amazon Posts Upbeat Results
April 28, 2023
U.S. stocks traded mixed this morning, following the release of several earnings reports. Following the market opening Friday, the Dow traded up 0.11% to 33,863.22 while the NASDAQ fell 0.25% to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
March 31, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 24, 2023
On Monday morning, 70 companies achieved new lows for the year.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 30, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Avidity Bio Crashes 26% After 'Rarer Than Rare' Event Sidelines Key Study
March 30, 2023
The company is working on a treatment for an inherited muscle-wasting disease.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
Analyst Says This Small Cap Biotech Firm Has 'Very Valuable Therapeutic,' Upgrades Stock
February 27, 2023
Via
Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
Peering Into Avidity Biosciences's Recent Short Interest
January 03, 2023
Avidity Biosciences's (NASDAQ:RNA) short percent of float has fallen 26.62% since its last report. The company recently reported that it has 6.51 million shares sold short, which is 11.33% of all...
Via
Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
December 15, 2022
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....
Via
Benzinga
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 15, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.